Evidence map›Paper›PMID 30971245›Full record

ArticleRespiratory research2019

AGER expression and alternative splicing in bronchial biopsies of smokers and never smokers.

Alen Faiz, Maarten van den Berge, Cornelis J Vermeulen, Nick H T Ten Hacken, Victor Guryev, Simon D Pouwels

Open access · goldAbstract readComparative StudyLetter
In one paragraph

Article in Respiratory research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.3field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 33 citations in OpenAlex.

  1. Review
  2. Lung Transcriptomics Link Emphysema to Barrier Dysfunction and Macrophage Subpopulations.American journal of respiratory and critical care medicine · 2025
    Article
  3. Article
  4. Blood-based Transcriptomic and Proteomic Biomarkers of Emphysema.American journal of respiratory and critical care medicine · 2024
    Article
  5. Review
  6. American journal of respiratory cell and molecular biology · 2023
    Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Alen FaizDepartment of Pathology & Medical Biology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713 GZ, Groningen, The Netherlands.
Maarten van den BergeGroningen Research Institute for Asthma and COPD, University Medical Center Groningen, Univesity of Groningen, Hanzeplein 1, 9713 GZ, Groningen, The Netherlands.
Cornelis J VermeulenGroningen Research Institute for Asthma and COPD, University Medical Center Groningen, Univesity of Groningen, Hanzeplein 1, 9713 GZ, Groningen, The Netherlands.
Nick H T Ten HackenGroningen Research Institute for Asthma and COPD, University Medical Center Groningen, Univesity of Groningen, Hanzeplein 1, 9713 GZ, Groningen, The Netherlands.
Victor GuryevGroningen Research Institute for Asthma and COPD, University Medical Center Groningen, Univesity of Groningen, Hanzeplein 1, 9713 GZ, Groningen, The Netherlands.
Simon D PouwelsDepartment of Pathology & Medical Biology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713 GZ, Groningen, The Netherlands. s.d.pouwels@umcg.nl.ORCID http://orcid.org/0000-0001-7345-8061
University Medical Center Groningen · NL

Funding

Netherlands Lung Foundation 6.2.15.044JONoordelijke CARA Stichting 2016/01
6 · The paper itself

Abstract

Cigarette smoking is one of the major risk factors for the development of chronic obstructive pulmonary disease (COPD). Evidence is accumulating that Receptor for Advanced Glycation-End products (RAGE)-signaling is a key pathway in the pathophysiology of COPD. To date, it is unknown how smoking affects RAGE expression. In the current study, we investigated the effect of smoking on AGER, the gene encoding RAGE, expression and on alternative splicing of AGER. To this end, we conducted RNA-Seq on bronchial biopsies for asymptomatic smokers (n = 36) and never smokers (n = 40). Total AGER gene expression was accessed using DESeq2, while alternative splicing was investigated by measuring the number of specific split reads spanning exon-exon junctions and the total split reads. One of the major isoforms of RAGE is endogenous soluble (es) RAGE, an anti-inflammatory decoy receptor, making up for approximately 10% of the total amount of soluble (s)RAGE. We found that smokers show decreased total gene expression of AGER in bronchial biopsies, while the relative abundance of the esRAGE isoform is increased. Furthermore, no difference in the serum levels of total sRAGE were observed between smokers and non-smokers. Our data indicates that smoking initiates a protective anti-inflammatory mechanism with decreased expression of the pro-inflammatory gene AGER and increased relative abundance of the anti-inflammatory isoform esRAGE.

Indexed as

SmokersAdultAlternative SplicingBiopsyCigarette SmokingFemaleGene ExpressionHumansLungMalePulmonary Disease, Chronic ObstructiveReceptor for Advanced Glycation End ProductsAGER protein, humanReceptor for Advanced Glycation End ProductsAGERAlternative splicingCigarette smokingCOPDRAGE

Identifiers

PMID30971245
PMCPMC6456980
OpenAlexW2939816926

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.